Gullberg & Jansson AB (publ) (XSAT:GJAB)
14.50
+1.40 (10.69%)
At close: Jun 12, 2026
Gullberg & Jansson AB Revenue
Gullberg & Jansson AB had revenue of 35.49M SEK in the quarter ending March 31, 2026, a decrease of -20.53%. This brings the company's revenue in the last twelve months to 261.44M, up 9.90% year-over-year. In the year 2025, Gullberg & Jansson AB had annual revenue of 270.61M with 10.90% growth.
Revenue (ttm)
261.44M
Revenue Growth
+9.90%
P/S Ratio
0.48
Revenue / Employee
6.54M
Employees
40
Market Cap
126.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 270.61M | 26.60M | 10.90% |
| Dec 31, 2024 | 244.01M | -15.02M | -5.80% |
| Dec 31, 2023 | 259.03M | -122.83M | -32.17% |
| Dec 31, 2022 | 381.86M | 13.23M | 3.59% |
| Dec 31, 2021 | 368.63M | 178.38M | 93.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SolidX AB | 137.67M |
| BPC Instruments AB | 65.77M |
| QBNK Holding AB | 40.29M |
| Aerowash AB | 35.69M |
| Redsense Medical AB | 28.70M |
| Touchtech AB | 23.12M |
| PEPTONIC medical AB | 14.42M |
| AcuCort AB | 7.44M |
Gullberg & Jansson AB News
- 5 weeks ago - Gullberg & Jansson AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Gullberg & Jansson AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Gullberg & Jansson AB Annual report: Q4 2025 - Filings
- 7 months ago - Gullberg & Jansson AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Gullberg & Jansson AB Quarterly report: Q2 2025 - Filings